These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14707727)
21. Cellular action of cholecystokinin-8S-mediated excitatory effects in the rat periaqueductal gray. Yang YM; Chung JM; Rhim H Life Sci; 2006 Sep; 79(18):1702-11. PubMed ID: 16797032 [TBL] [Abstract][Full Text] [Related]
22. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Ohlsson B; Fredäng N; Axelson J Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070 [TBL] [Abstract][Full Text] [Related]
23. Lectin binding studies with FITC-marked WGA and UEA I and flowcytometric measurements on isolated rat pancreatic acinar cells. Jonas L; Fulda G; Walzel H; Schulz U Acta Histochem; 1993 Sep; 95(1):45-52. PubMed ID: 8279234 [TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295 [TBL] [Abstract][Full Text] [Related]
26. Modulation of cholecystokinin activity by albumin. Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774 [TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons. Wan S; Coleman FH; Travagli RA Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742 [TBL] [Abstract][Full Text] [Related]
28. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Pandya PK; Huang SC; Talkad VD; Wank SA; Gardner JD Biochim Biophys Acta; 1994 Oct; 1224(1):117-26. PubMed ID: 7948036 [TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. Zavros Y; Shulkes A J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654 [TBL] [Abstract][Full Text] [Related]
30. Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin a nor cholecystokinin B receptors mediate amylase secretion in vitro. Miyasaka K; Shinozaki H; Jimi A; Funakoshi A Pancreas; 2002 Aug; 25(2):161-5. PubMed ID: 12142739 [TBL] [Abstract][Full Text] [Related]
31. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983 [TBL] [Abstract][Full Text] [Related]
32. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas. Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956 [TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Povoski SP; Zhou W; Longnecker DS; Bell RH Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527 [TBL] [Abstract][Full Text] [Related]
34. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies. Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648 [TBL] [Abstract][Full Text] [Related]
35. Wheat germ agglutinin, concanavalin A, and lens culinalis agglutinin block the inhibitory effect of nerve growth factor on cell-free phosphorylation of Nsp100 in PC12h cells. Hashimoto S; Hagino A Cell Struct Funct; 1989 Feb; 14(1):87-93. PubMed ID: 2720800 [TBL] [Abstract][Full Text] [Related]
36. Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells. Schaeffer P; Nestor AL; Prabonnaud V; Bachy A; Laplace MC; Keane PE; Bignon E; Herbert JM Eur J Pharmacol; 2000 Jun; 397(2-3):303-10. PubMed ID: 10844128 [TBL] [Abstract][Full Text] [Related]
37. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells. Meyer G; Beinborn M; Sewing KF Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601 [TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice. Maletínská L; Maixnerová J; Matysková R; Haugvicová R; Pirník Z; Kiss A; Zelezná B BMC Neurosci; 2008 Oct; 9():101. PubMed ID: 18939974 [TBL] [Abstract][Full Text] [Related]
39. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells. Dunlop J; Zhang Y; Evans N Peptides; 1997; 18(6):865-8. PubMed ID: 9285936 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of human and porcine alpha-amylase on CCK-8-stimulated lipase secretion of isolated rat pancreatic acini. Jonas L; Mikkat U; Lehmann R; Schareck W; Walzel H; Schröder W; Lopp H; Püssa T; Toomik P Pancreatology; 2003; 3(4):342-8. PubMed ID: 12890998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]